Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Ah Bio Fund Ii, L.p.
Over the trailing 90 days, Ah Bio Fund Ii, L.p. (Other at Scribe Therapeutics, Inc.) traded $16.7M of stock (net selling $6.8M) across 2 companies, per 7 SEC Form 4 transactions.
- Role
- Other
- Window
- Trailing 90 days · 7 transactions · CIK 1725721
- Net activity
- −$6.8M ($5.0M bought · $11.8M sold)
By Company (Trailing 90 Days)
Transactions (7)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-27 | SCTX | Sell | 4.1M | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Buy | 333.3K | $5.0M | Open market or private purchase |
| 2026-07-27 | SCTX | Buy | 697.6K | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Buy | 2.1M | $0 | Conversion of derivative security |
| 2026-07-27 | SCTX | Sell | 12.2M | $0 | Conversion of derivative security |
| 2026-06-02 | NAUT | Sell | 384.0K | $902K | Open market or private sale |
| 2026-06-02 | NAUT | Sell | 4.6M | $10.8M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Ah's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.